Clinical trial
Clinical Course of Treatment With ESBRIET in Patients With Mild to Moderate IPF
NCT02622477 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Course of Treatment With ESBRIET in Patients With Mild to Moderate IPF
- Lead sponsor
- Hoffmann-La Roche
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2014
- Completion date
- December 31, 2016
- Enrollment
- 12 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.